Across the recent three months, 13 analysts have shared their insights on Tenet Healthcare THC, expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 9 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 3 | 4 | 0 | 0 | 0 |
| 2M Ago | 1 | 4 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Tenet Healthcare and provided 12-month price targets. The average target is $189.54, accompanied by a high estimate of $217.00 and a low estimate of $168.00. Marking an increase of 6.58%, the current average surpasses the previous average price target of $177.83.
Interpreting Analyst Ratings: A Closer Look
A clear picture of Tenet Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Ransom | Raymond James | Maintains | Outperform | $195.00 | $195.00 |
| Andrew Mok | Barclays | Raises | Overweight | $190.00 | $171.00 |
| Stephen Baxter | Wells Fargo | Raises | Overweight | $205.00 | $195.00 |
| Sarah James | Cantor Fitzgerald | Raises | Overweight | $177.00 | $168.00 |
| Jamie Perse | Goldman Sachs | Raises | Buy | $196.00 | $173.00 |
| Ben Hendrix | RBC Capital | Raises | Outperform | $183.00 | $174.00 |
| David Macdonald | Truist Securities | Raises | Buy | $190.00 | $180.00 |
| A.J. Rice | UBS | Raises | Buy | $217.00 | $197.00 |
| Stephen Baxter | Wells Fargo | Raises | Overweight | $195.00 | $175.00 |
| David Macdonald | Truist Securities | Raises | Buy | $180.00 | $170.00 |
| Matthew Gillmor | Keybanc | Announces | Overweight | $200.00 | - |
| Sarah James | Cantor Fitzgerald | Maintains | Overweight | $168.00 | $168.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Overweight | $168.00 | $168.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Tenet Healthcare. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Tenet Healthcare compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Tenet Healthcare's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into Tenet Healthcare's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Tenet Healthcare analyst ratings.
Delving into Tenet Healthcare's Background
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Key Indicators: Tenet Healthcare's Financial Health
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Tenet Healthcare's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 1.11%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Tenet Healthcare's net margin excels beyond industry benchmarks, reaching 9.22%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Tenet Healthcare's ROE stands out, surpassing industry averages. With an impressive ROE of 12.92%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Tenet Healthcare's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.61% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Tenet Healthcare's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 3.36.
The Basics of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
